Dr. Chul Kim

Doctor Overview

Dr. Chul Kim is the director of thoracic oncology at MedStar Georgetown University Hospital. The Georgetown Lombardi Comprehensive Cancer Center is part of this system. He has experience treating cancers of the lining around the lungs (pleura), including pleural mesothelioma. He also specializes in treating lung cancer, which can be caused by asbestos exposure.

After receiving his medical degree from Sungkyunkwan University in Seoul, South Korea, Dr. Kim earned a Master of Public Health (MPH) from the Harvard School of Public Health. He later served as a fellow at the National Cancer Institute (NCI), the U.S. government's top agency for cancer research.

Dr. Kim has been published in over 60 articles in peer-reviewed journals. He has also served as a reviewer for many of his colleagues' articles. He is committed to developing innovative cancer treatments through research and clinical work.

Doctor Fast Facts

Main Specialty: Thoracic Oncology

Other Interests & Specialties: Geriatric oncology consulting, immune cell therapy, immunotherapy, palliative care, pleural cancer, tumor immunohistochemistry and vaccine development.

Certifications, Awards & Accolades: American Society of Clinical Oncology, Conquer Cancer Foundation’s Norman Rales Young Investigator Award, Georgetown Lombardi Comprehensive Cancer Center’s John F. Potter, MD, Award, International Association for the Study of Lung Cancer

Education & Experience:

• Medical Degree from Sungkyunkwan University
• Residency in Internal Medicine at University of Minnesota
• Fellowship in Hematology and Oncology at NCI

Publications

Discordant Response to Nivolumab Plus Ipilimumab and Identification of BRAF V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case Report. JTO Clin Res Rep. 2025 May;6(5):100820.